After careful reading of the remaining articles, 29 studies were removed, because the exposure/event of interest was not reported
Side effects: what the FDA labels actually list Both pills are GLP-1s, so most of what youll feel is the same either way, and its mostly your gut
The spectrum ranges from simple steatosis (fat accumulation) to non-alcoholic steatohepatitis (NASH, now termed MASH or metabolic dysfunction-associated steatohepatitis), which involves inflammation and can progress to cirrhosis and liver failure
Zhu et al., using a HFD-induced NAFLD mouse model, showed that body weight, LFTs, lipid profile, glucose, and insulin tolerance as well as hepatic steatosis were improved after 4 weeks of liraglutide treatment